Key Benefits
• Promotes growth and reproductive development through zinc bio-enrichment• Superior zinc bioavailability compared to inorganic zinc oxide• Enhances intestinal zinc absorption
Key Data
• Organic zinc content in CCFM1195 powder: 96.47% (intracellular) vs. 45.49% (cell wall‑bound when mixed with ZnO)• Zinc absorption pathway: absorbed into blood → binds to albumin (>94%) → transported to liver (67‑80% of total absorbed)• Serum zinc and liver zinc deposition: CCFM1195‑enriched > CCFM1195+ZnO > ZnO alone• SCFAs produced by the strain lower intestinal pH, increasing zinc solubility and absorption surface area
Patent
National Invention Patent – A zinc‑enriched Bifidobacterium longum strain for promoting growth and reproductive development and its application
Why Choose CCFM1195?
Unique zinc‑enrichment technology – addresses the growing consumer demand for natural, bio‑available mineral supplementation, especially in pediatric nutrition
Significantly higher bioavailability than conventional zinc oxide, meaning lower dosages needed for equivalent efficacy – a strong cost‑performance advantage for formulators
Addresses a critical nutritional gap – zinc deficiency affects growth, immune function, and reproductive health in children, making this strain highly relevant for pediatric products
Ideal for children's health supplements, growth‑support formulas, and functional foods targeting nutritional fortification
